Press Release Teva Delivers Strong Q2 Results and Raises Outlook for All Three Key Innovative Brands, Reflecting Continued Execution of Its Pivot to Growth Strategy Teva Pharmaceutical Industries Ltd · Jul 29
Press Release Trace Biosciences Announces Strategic Investment from Axogen to Advance Clinical Development of its Nerve Trace Nerve-Specific Imaging Technology Trace Biosciences · Jul 29
Press Release TScan Therapeutics Announces First Patient Dosed in Phase 3 ALLOHA-2™, a Pivotal Trial Evaluating TSC-101 in Patients with Heme Malignancies TScan Therapeutics, Inc. · Jul 29
Press Release Ceribell Expands Board of Directors with Appointments of Thomas West and Sharon O’Keefe Ceribell · Jul 29
Press Release Bull DeFi Announces Platform Milestone and Expanded Global Computing Infrastructure Bull DeFi · Jul 29
Press Release Interest in Disability Insurance for Veterinarians Triples in 12 Months Set for Life Insurance · Jul 29
Press Release uniQure Announces Second Quarter 2026 Financial Results and Provides Company Update uniQure Inc. · Jul 29
Press Release Ocugen Announces that the U.S. Food and Drug Administration Has Granted OCU410 Regenerative Medicine Advanced Therapy (RMAT) Designation for Treatment of Geographic Atrophy, Secondary to Dry Age-Related Macular Degeneration Ocugen · Jul 29
Press Release Aquestive Therapeutics to Report Second Quarter 2026 Financial Results and Recent Business Highlights on August 11 and Host Conference Call on August 12 at 8:00 a.m. ET Aquestive Therapeutics, Inc. · Jul 29
Press Release Aclarion Publishes CEO Shareholder Letter Highlighting Progress for First Half of 2026 Aclarion, Inc. · Jul 29
Press Release VisionWave Files U.S. Non-Provisional Patent Application for DeepWave RF™, an AI-Powered Subsurface Sensing and Visualization Platform VisionWave Holdings, Inc. · Jul 29
Press Release Freehand Raises $75M to Scale AI Teams Managing Supply Chain Spend for Fortune 500 Companies Freehand · Jul 29